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We conducted a randomized clinical trial to determine whether treatment of women




We randomly assigned women between 24 and 34 weeks’ gestation who had gestation-
al diabetes to receive dietary advice, blood glucose monitoring, and insulin therapy as
needed (the intervention group) or routine care. Primary outcomes included serious
perinatal complications (defined as death, shoulder dystocia, bone fracture, and nerve
palsy), admission to the neonatal nursery, jaundice requiring phototherapy, induction




The rate of serious perinatal complications was significantly lower among the infants
of the 490 women in the intervention group than among the infants of the 510 women
in the routine-care group (1 percent vs. 4 percent; relative risk adjusted for maternal
age, race or ethnic group, and parity, 0.33; 95 percent confidence interval, 0.14 to 0.75;
P=0.01). However, more infants of women in the intervention group were admitted to
the neonatal nursery (71 percent vs. 61 percent; adjusted relative risk, 1.13; 95 percent
confidence interval, 1.03 to 1.23; P=0.01). Women in the intervention group had a high-
er rate of induction of labor than the women in the routine-care group (39 percent vs.
29 percent; adjusted relative risk, 1.36; 95 percent confidence interval, 1.15 to 1.62;
P<0.001), although the rates of cesarean delivery were similar (31 percent and 32 per-
cent, respectively; adjusted relative risk, 0.97; 95 percent confidence interval, 0.81 to
1.16; P=0.73). At three months post partum, data on the women’s mood and quality of
life, available for 573 women, revealed lower rates of depression and higher scores, con-




Treatment of gestational diabetes reduces serious perinatal morbidity and may also
improve the woman’s health-related quality of life.
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estational diabetes mellitus oc-
 




and is associated with substantial rates
of maternal and perinatal complications. The risk of




 but the risk of
macrosomia is. Other perinatal risks include shoul-
der dystocia, birth injuries such as bone fractures
and nerve palsies, and hypoglycemia. Long-term ad-
verse health outcomes reported among infants born
to mothers with gestational diabetes include sus-
























Although the risks associated with gestational
diabetes are well recognized, it remains uncertain
whether screening and treatment to reduce mater-
nal glucose levels reduce these risks. Given this un-
certainty, professional groups disagree on whether
to recommend routine screening, selective screen-
ing based on risk factors for gestational diabetes, or








 There have been repeat-
ed calls for well-designed, randomized trials to de-
termine the efficacy of screening, diagnosis, and





designed the Australian Carbohydrate Intolerance
Study in Pregnant Women (ACHOIS) trial to assess
whether the treatment of gestational diabetes would
reduce perinatal complications and to assess the ef-
fects of treatment on maternal outcome, mood, and
quality of life.
 
design and study population
 
Eligible women had a singleton or twin pregnancy
between 16 and 30 weeks’ gestation, attended ante-
natal clinics at the collaborating hospitals, had one
or more risk factors for gestational diabetes on se-
lective screening or a positive 50-g oral glucose-
challenge test (glucose level one hour after glucose
challenge at least 7.8 mmol per liter [140 mg per
deciliter]), and had a 75-g oral glucose-tolerance
test at 24 to 34 weeks’ gestation in which the ve-
nous plasma glucose level was less than 7.8 mmol
per liter after an overnight fast and was 7.8 to 11.0




When the study was initiated, women meeting these
criteria were classified as having glucose intolerance
of pregnancy, on the basis of the World Health Or-
ganization (WHO) definition: a glycemic response
to a standard oral glucose-tolerance test that was
intermediate between the normal and diabetic re-
sponse, with an onset or recognition of the condi-




 From 1998 on-
ward, the WHO classified any glucose levels above





en with more severe glucose impairment were not
eligible for this trial.
Women were advised to follow a normal diet 48
hours before the oral glucose-tolerance test and to
fast for 8 hours the night before the test. Blood sam-
ples were obtained after the overnight fast and one
and two hours after the receipt of the 75-g oral glu-
cose load. Women with previously treated gestation-
al diabetes or active chronic systemic disease (except
essential hypertension) were excluded. 
The protocol was approved by the ethics com-
mittee at each of the 18 collaborating centers (14
in Australia and 4 in the United Kingdom). All
women provided written informed consent. None
of the funding bodies were involved in the trial de-
sign or conduct; collection, analysis, or interpreta-
tion of the data; or preparation, review, or approval
of the manuscript.
Women were provided with written informa-
tion about the study, and this information was re-
viewed with them orally before their oral glucose-
tolerance test. They were informed that they would
be eligible for randomization only if their results
were in the range specified above. If they were as-
signed to the intervention group, they received a
slip indicating a diagnosis of glucose intolerance
of pregnancy and the plan for intervention, where-
as if they were assigned to routine care, they re-
ceived a slip indicating that they did not have ges-
tational diabetes. This approach was continued
throughout the trial, because there remained un-
certainty as to the level of glucose impairment as-





was wide variation in the glucose levels used to de-













 made changes in the no-
menclature; and there was still no clear evidence of





consent had been obtained, a proportion of the
women (not fewer than one in five) who had nor-
mal oral glucose-tolerance test results were as-
signed to the routine-care group to help maintain
blinding. Women whose glucose levels exceeded
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Stratification was according to center and singleton
or twin gestation. Randomization was performed
centrally with the use of numbers generated by
computer with variable block sizes of 6, 8, and 10.
The full numerical results of the oral glucose-toler-
ance test were not released to the women or their
providers until after birth, before discharge from the
hospital.
Women who were randomly assigned to the in-
tervention group received ongoing care by the at-
tending obstetrical team with a physician’s support.
Interventions included individualized dietary ad-
vice from a qualified dietitian, which took into con-
sideration a woman’s prepregnancy weight, activity
level, dietary intake, and weight gain; instructions
on how to self-monitor glucose levels, which the
woman was then asked to do four times daily until
the levels had been in the recommended range for
2 weeks (fasting glucose levels of at least 3.5 mmol
per liter [63 mg per deciliter] and no more than 5.5
mmol per liter [99 mg per deciliter], preprandial
levels of no more than 5.5 mmol per liter, and lev-
els two hours postprandially that were no more
than 7.0 mmol per liter [126 mg per deciliter]), fol-
lowed by daily monitoring at rotating times during
the day; and insulin therapy, with the dose adjusted
on the basis of glucose levels, if there were two cap-
illary-blood glucose results during the 2-week peri-
od in which the fasting level was at least 5.5 mmol
per liter or the postprandial level was at least 7.0
mmol per liter at 35 weeks’ gestation or less, if the
postprandial level was at least 8.0 mmol per liter
(144 mg per deciliter) at more than 35 weeks’ ges-
tation, or if one capillary-blood glucose result dur-
ing the 2-week period was at least 9.0 mmol per liter
(162 mg per deciliter).
The care of the women in the intervention group
replicated clinical care in which universal screening
and treatment for gestational diabetes are available.
Women in the routine-care group and their care-
givers were unaware of the diagnosis of glucose in-
tolerance of pregnancy. At the discretion of the at-
tending clinician, if indications arose that were
suggestive of diabetes, further assessment for ges-
tational diabetes was permitted, with treatment as
considered appropriate. The care of the women in
the routine-care group replicated clinical care in
which screening for gestational diabetes is not avail-
able. The care women and infants received was oth-
erwise according to standard practice at each center.
A research assistant extracted data on treatment
from the medical records of the woman and her in-
fant to the time of hospital discharge as well as on




Primary outcomes among the infants were a com-
posite measure of serious perinatal complications
(defined as one or more of the following: death,
shoulder dystocia, bone fracture, and nerve palsy),
admission to the neonatal nursery, and jaundice re-
quiring phototherapy. The presence and severity of
shoulder dystocia were assessed by means of a
standardized checklist completed by the caregiver
present at the birth.
Primary clinical outcomes among the women
were the need for induction of labor and cesarean
section. Maternal health status was assessed by
means of the Medical Outcomes Study 36-Item
Short-Form General Health Survey (SF-36), which
assesses eight aspects of health status: general and
mental health, physical and social functioning,
physical and emotional role, pain, and vitality;





 Maternal psychological outcomes in-
cluded measures of anxiety, depression, and health-
related quality of life. Anxiety was assessed with the





 a self-rating scale consisting
of 6 items (scores below 15 are considered normal).
The presence of depression was reflected by a score





 Questionnaires were mailed six weeks
after study entry and at three months post partum
to 916 women (92 percent of the total) recruited to
the study after funding for this assessment became
available.
Secondary outcomes among the infants includ-
ed components of the composite primary outcome,
gestational age at birth, birth weight, and other
measures of health. Secondary outcomes among
the women included the number of prenatal visits
to a health professional, the mode of birth, weight
gain during pregnancy, the number of antenatal ad-
missions, and the presence or absence of pregnan-
cy-induced hypertension (defined as a blood pres-
sure of at least 140/90 mm Hg on two occasions four




Statistical analyses were based on the intention to
treat and used SAS software, version 8.2 (SAS Insti-
tute). Analyses were adjusted for maternal age, race
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or ethnic group, and parity. Binary outcomes are
presented as relative risks, with 95 percent confi-
dence intervals; the number needed to treat to ben-
efit (i.e., the number of patients who would need to
be treated for a benefit in one patient) and the num-
ber needed to treat to harm (i.e., the number of pa-
tients who would need to be treated for harm to oc-





 are presented for primary clinical out-
comes. Relative risks were calculated with the use
of log binomial regression. Continuous variables
were analyzed by means of analysis of variance if
they were normally distributed and by means of
nonparametric tests if their distribution was not
normal. The health state utility was calculated from




With no evidence of increased variance owing to the
small number of twins in the study, no adjustment
was made for clustering of babies with the same
mothers. A P value of 0.05 was considered to indi-
cate statistical significance; all P values were two-
sided. A step-down Sidak adjustment was made for





We estimated that we would need to enroll 1000
women for the study to have a statistical power of
80 percent (two-sided alpha value of 0.05) to detect
a reduction in the risk of a serious perinatal outcome
from 5.2 percent to 2.0 percent, using outcomes re-





from Women’s and Children’s Hospital in Adelaide.
Data were reviewed once in January 1999 by our
independent data-monitoring committee, whose
members were unaware of the treatment assign-
ments, after the enrollment of 460 women. The
study protocol included a prespecified stopping rule
for a difference in a major end point of at least 3 SD
between the groups. 
Of the 1000 women enrolled in the study, 490 were
assigned to the intervention group and 510 to the
routine-care group (Fig. 1). Recruitment started in
September 1993 and stopped in June 2003, after
1000 women had been enrolled. Clinical outcomes
were obtained up to the time of hospital discharge
for all women and their 1030 infants.
On the whole, the two groups were similar at
entry. As compared with the women in the routine-
care group, women in the intervention group were
older and were less likely to be white or primipa-
rous (Table 1). Ninety-three percent of the women
had been found to be at risk for gestational diabe-
tes on the basis of the oral glucose-challenge test,




The rate of serious perinatal outcomes among the
infants (defined by one or more of the following:
death, shoulder dystocia, bone fracture, and nerve
palsy) was significantly lower in the intervention
group than the routine-care group (1 percent vs.
4 percent; P=0.01, adjusted for maternal age, race
or ethnic group, and parity (Table 2). Thus, the num-
ber needed to treat to prevent a serious outcome in
an infant was 34 (95 percent confidence interval,
20 to 103). A higher percentage of infants born to
women in the intervention group than of infants
born to women in the routine-care group were ad-
mitted to the neonatal nursery (71 percent vs. 61
percent, adjusted P=0.01). The length of stay in the
neonatal nursery among the infants who were ad-
results
 




       to intervention group
    0 Lost to follow-up
510 Women assigned
to routine-care group
    0 Lost to follow-up
332 Women completed SF-36 
6 wk after entry
350 Women completed  SF-36 
6 wk after entry
506 Live births
0 Stillbirths after randomization
0 Infants died before initial
hospital discharge
524 Live births
3 Stillbirths after randomization
2 Infants died before initial
hospital discharge
490 Women included in the 
primary maternal analyses
506 Infants included in the 
primary infant analyses 
510 Women included in the 
primary maternal analyses
524 Infants included in the 
primary infant analyses 
278 Women included in the 
quality-of-life outcomes
at 3 mo post partum
295 Women included in the 
quality-of-life outcomes
at 3 mo post partum
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mitted did not differ significantly between groups
(median of 1 day for both groups; interquartile
range, 1 to 2 days in the intervention group and 1 to
3 days in the routine-care group; adjusted P=0.81).
There was no significant difference in the percent-
age of infants who had jaundice requiring photo-
therapy in the two groups (adjusted P=0.72) (Ta-
ble 2).
The induction of labor was significantly more
common in the intervention group than in the rou-
tine-care group (39 percent vs. 29 percent; adjusted
P<0.001) (Table 2). The rates of cesarean delivery
were similar in the two groups (adjusted P=0.73)
(Table 2), as were the reasons for cesarean delivery.
Step-down Sidak adjustments were made to cor-
rect for the analyses of multiple primary clinical end
points (Table 2). The results remained consistent
across these analyses, with the intervention group
having a reduced risk of serious perinatal outcomes
(corrected P=0.04) and an increased likelihood of
admission to the neonatal nursery for the infant
(corrected P=0.04) and use of induction of labor
for the mother (corrected P=0.003).
Maternal health status was measured in 682
women (68 percent) who completed the question-
naires six weeks after enrollment and 573 women
(57 percent) who completed them three months
post partum. Women who completed assessments
were slightly older than, but otherwise similar to,
women who did not.




 showed trends in fa-
vor of the intervention group, although not all were
significant (Table 3). At three months post partum,
fewer women in the intervention group than in the





 suggestive of depres-
sion (23 vs. 50 [8 percent vs. 17 percent]). The level




No perinatal deaths occurred among the infants of
mothers in the intervention group, but there were
five perinatal deaths (three stillbirths and two neo-
natal deaths) among infants born to women in the
routine-care group (Fig. 1 and Table 2). Two still-
births were unexplained intrauterine deaths at term
of appropriately grown infants, and the other, at 35
weeks’ gestation, was associated with preeclamp-
sia and intrauterine growth restriction. One infant
had a lethal congenital anomaly, and one infant died
after an asphyxial condition during labor without
antepartum hemorrhage.
There was no significant difference in the rates
of shoulder dystocia between the intervention and
routine-care groups (1 percent and 3 percent, re-
spectively) (Table 2). No infant in the intervention
group had a bone fracture or nerve palsy, whereas
in the routine-care group, one infant had both a
fractured humerus that was not related to a difficult
birth and a radial-nerve palsy, one infant had Erb’s
palsy related to shoulder dystocia, and one infant
had Erb’s palsy alone (Table 2).
Infants born to women in the intervention group
had significantly lower mean birth weights than
infants born to women in the routine-care group
(P<0.001) (Table 4), and they were also born at an
earlier gestational age, in keeping with the higher
incidence of induction of labor in their mothers (Ta-
ble 5). Significantly fewer infants in the intervention
 
* Plus–minus values are means ±SD. OGCT denotes oral glucose-challenge 
test, and OGTT oral glucose-tolerance test.
† Data are from the first trimester. The body-mass index is the weight in kilo-
grams divided by the square of the height in meters.
 
‡ Race or ethnic group was self-reported.
 







Age — yr 30.9±5.4  30.1±5.5
Primiparous — no. (%)  212 (43)  251 (49)
Body-mass index†  
Median 26.8  26.0
Interquartile range 23.3–31.2 22.9–30.9
Race or ethnic group — no. (%)‡
White  356 (73)  396 (78)
Asian  92 (19)  72 (14)
Other  42 (9)  42 (8)
Gestational age at entry — wk
Median 29.1 29.2 
Interquartile range 28.2–30.0 28.2–30.0
OGCT — mmol/liter
Median  8.8  8.8
Interquartile range 8.2–9.7 8.3–9.7




Interquartile range 8.1–9.3 8.1-9.1
Previous pregnancy ending 
in perinatal death 
— no./total no. (%)
 12/278 (4)  7/259 (3)
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group were large for gestational age at birth, and
significantly fewer had macrosomia (defined by a
birth weight of 4 kg or greater) (Table 4). There
was no significant difference between groups in the
proportion of infants who were small for gesta-
tional age.
Women in the intervention group had fewer an-
tenatal clinic visits after enrollment than did wom-
en in the routine-care group, but they had more
visits to the physician and were significantly more
likely to see a dietitian and a diabetes educator
(Table 5). One hundred women in the intervention
group (20 percent) received insulin therapy, as com-
pared with 17 in the routine-care group (3 percent).
Weight gain from the booking appointment to the
last antenatal visit was less in the intervention group
than in the routine-care group (Table 5). The rates
of antenatal hospital admissions were similar in
the two groups. Fewer women in the intervention
group than in the routine-care group received a di-
agnosis of preeclampsia during the antenatal peri-
od (Table 5).
In this randomized clinical trial, treatment of wom-
en with gestational diabetes — including dietary ad-
vice, blood glucose monitoring, and insulin thera-
py — reduced the rate of serious perinatal outcomes
(defined as death, shoulder dystocia, bone fracture,
and nerve palsy) from 4 percent to 1 percent. These
benefits were associated with an increased use of
discussion
 
* CI denotes confidence interval.
† Values were adjusted for maternal age, race or ethnic group, and parity.
‡ Serious perinatal complications were defined as one or more of the following: death, shoulder dystocia, bone fracture, and nerve palsy. The 
number needed to treat to benefit was 34 (95 percent confidence interval, 20 to 103).
§ Gestational ages at delivery for the three stillborn infants were 35, 37, and 40 weeks.
¶ Shoulder dystocia was recorded by the primary caregiver present at the birth.
¿ One infant had both a fractured humerus and a radial-nerve palsy. One infant had both shoulder dystocia and Erb’s palsy.
** The number needed to treat to harm was 11 (95 percent confidence interval, 7 to 29).
†† Indications for the induction of labor in the intervention and routine-care groups were as follows: gestational diabetes in 23 percent and 
4 percent, respectively; preeclampsia in 6 percent and 12 percent, respectively; past due dates in 8 percent of each group; fetal compromise 
in 5 percent and 2 percent, respectively; and other indications in 5 percent and 3 percent, respectively. The number needed to treat to harm 
 
was 11 (95 percent confidence interval, 7 to 31).
 























Total no. 506 524 
Any serious perinatal complication‡ 7 (1)  23 (4) 0.32 (0.14–0.73) 0.004 0.33 (0.14–0.75) 0.01 0.04
Death 0 5 (1) 0.06 0.07
Stillbirth 0 3 (1)§ 0.25 0.26
Neonatal death 0 2 (<1) 0.50 0.50
Shoulder dystocia¶ 7 (1) 16 (3) 0.45 (0.19–1.09) 0.07 0.46 (0.19–1.10) 0.08
Bone fracture 0 1 (<1) 1.00 0.38
Nerve palsy 0 3 (1)¿ 0.25 0.11
Admission to neonatal nursery** 357 (71) 321 (61) 1.15 (1.05–1.26) 0.002 1.13 (1.03–1.23) 0.01 0.04




Total no. 490 510 
 Induction of labor†† 189 (39) 150 (29) 1.31 (1.10–1.56) 0.002 1.36 (1.15–1.62) <0.001  0.003
 Cesarean delivery 152 (31)  164 (32) 0.96 (0.80–1.16) 0.70 0.97 (0.81–1.16) 0.73 0.98
Elective 72 (15)  61 (12) 1.23 (0.89–1.69) 0.20 1.17 (0.85–1.60) 0.33
Emergency 80 (16) 103 (20) 0.81 (0.62–1.05) 0.11 0.87 (0.68–1.13) 0.31
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induction of labor for the mother and an increased
rate of admission to the neonatal nursery for the in-
fant, both of which may be related to the knowledge
of the diagnosis by the attending physician. The ear-
lier gestational age at birth as a consequence of the
induction of labor may have contributed to the re-
duction in serious perinatal outcomes. Others have
reported an increased rate of cesarean delivery as-





 In our study, the rate of cesarean
delivery was similar in the two groups.
We chose primary clinical outcomes to assess
the effects of treatment for gestational diabetes on
both the mothers and the infants. Differences be-
 
* The quality of life was first measured six weeks after enrollment. Plus–minus values are means ±SD. CI denotes confi-
dence interval, and EPDS the Edinburgh Postnatal Depression Scale.
† Values were adjusted for maternal age, race or ethnic group, and parity. The adjusted treatment effect is expressed as the 
mean difference between groups for all outcomes except an EPDS score higher than 12, for which the treatment effect is 
expressed as the relative risk.
‡ Scores for the SF-36 can range from 0 (worst) to 100 (best).




Table 3. Quality of Life during Pregnancy and Three Months after Giving Birth.*






6 Wk after enrollment
 
No. of women 332 350
SF-36 score‡
Physical functioning 56.4±23.1  54.0±22.7  2.5 (¡1.0 to 6.0) 0.16
Physical role  40.7±41.4  32.4±38.1  8.6 (2.5 to 14.6) 0.01
Bodily pain  63.1±24.6  59.0±24.1  4.1 (0.4 to 7.8) 0.03
General health  73.4±17.4  72.5±18.9  1.0 (¡1.8 to 3.7) 0.48
Vitality  50.0±21.0  46.7±20.3  3.1 (0.1 to 6.1) 0.04
Social functioning  73.5±24.0  70.9±23.2  2.9 (¡0.7 to 6.5) 0.11
Emotional role  77.5±35.3  69.1±40.9  9.4 (3.5 to 15.2) 0.002
Mental health  75.1±15.4  73.8±16.6  1.4 (¡1.1 to 3.8) 0.27
Overall physical component  38.8±9.4  37.3±9.0  1.5 (¡0.1 to 2.9) 0.04
Overall mental component  50.9±9.2  49.6±10.4  1.2 (¡0.3 to 2.7) 0.11
Health state utility  0.72±0.11  0.70±0.11  0.03 (0.01 to 0.04) 0.005
Anxiety§  11.2± 3.7  11.5±4.0 ¡0.4 (¡1.0 to 0.2)  0.17
 
3 Mo post partum
 
No. of women 278 295
SF-36 score‡
Physical functioning  85.8±19.5  83.6±19.6  3.2 (0.1 to 6.3) 0.05
Role physical  79.9±33.7  75.9±36.3  5.3 (¡0.4 to 11.1) 0.07
Bodily pain  77.7±23.0  77.3±21.6  1.1 (¡2.6 to 4.7) 0.57
General health  76.8±17.5  74.2±18.2  3.2 (0.2 to 6.1) 0.03
Vitality  60.0±19.3  57.7±19.7  2.2 (¡1.1 to 5.4) 0.19
Social functioning  81.4±21.3  70.0±23.3  3.2 (¡0.4 to 6.8) 0.09
Role emotional  78.9±35.0  78.5±35.7  1.6 (¡4.3 to 7.4) 0.60
Mental health  77.0±15.4  77.4±16.7  0.1 (¡2.7 to 2.6) 0.96
Overall physical component  51.2±8.5  50.0±8.5  1.5 (0.1 to 2.9) 0.03
Overall mental component  48.6±10.0  48.4±10.9  0.3 (¡1.5 to 2.1) 0.72
Health state utility  0.79±0.10  0.78±0.11  0.01 (¡0.01 to 0.03) 0.22
Anxiety score§  10.6±3.9  10.8±3.8  ¡0.3 (¡0.9 to 0.4) 0.41
EPDS score >12 — no. (%)  23 (8)  50 (17)  0.46 (0.29 to 0.73) 0.001
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tween groups remained significant after adjustment
for known confounders (maternal age, race or eth-
nic group, and parity) and for analyses involving
multiple primary end points.
Infants born to mothers receiving intensive ther-
apy had lower birth weights than those born to
women receiving routine care, an observation that
may be explained at least in part by the earlier ges-
tational age at birth in this group, related to the in-
creased use of induction of labor. Infants in this
group were no more likely to be small for gestation-
al age, but they were significantly less likely to be
large for gestational age and to have macrosomia.
Infants who are large for gestational age are prone










 Long-term follow-up is needed to assess
whether the lower birth weights among the infants
in the intervention group will translate into reduced
rates of these later complications.
Despite the increased rate of admission to the
neonatal nursery in the intervention group, there
were no significant differences between the groups
of infants in secondary clinical outcomes, such as
hypoglycemia requiring intravenous therapy. As
compared with the women in the routine-care
group, the women in the intervention group made
more visits to the medical clinic and were more
likely to see a dietitian and diabetes educator. How-
ever, they made fewer antenatal clinic visits, a differ-
ence that was most likely related to their increased
likelihood of induction and their infants’ earlier ges-
tational age at birth. The reduction in the risk of
preeclampsia in the intervention group may be re-
lated to the earlier gestational age at birth.
A potentially controversial aspect of our study
design from an ethical standpoint was the fact that
women were not informed of their diagnosis of
“gestational diabetes” during the course of the
study, after the change in the WHO criteria. How-





 there continued to be no
conclusive evidence regarding the effects of treat-




 and there were





 Women in the study received stan-
dard pregnancy care consistent with care in which
screening for gestational diabetes is not routine.
Our trial also revealed an improved health-relat-
ed quality of life among women in the intervention
group, both during the antenatal period and three
months after birth, together with a reduction in the
incidence of depression after birth. These findings
are contrary to reports suggesting a decline in wom-
en’s perception of their own health after they receive





results for these outcomes should be interpreted
with caution, since the analysis included only a
subgroup of the women.
There has been a lack of data from large ran-
 
* Plus–minus values are means ±SD. CI denotes confidence interval, and IV intravenous.
† Values were adjusted for maternal age, race or ethnic group, and parity. The adjusted treatment effect is expressed as the 
mean difference between groups for birth weight and as the relative risk for the other outcomes.








¶The hypoglycemia level requiring therapy was determined by the clinician.
















Birth weight — g  3335±551  3482±660  ¡145 (¡219 to ¡70) <0.001
Large for gestational age — no. (%)‡  68 (13)  115 (22)  0.62 (0.47 to 0.81) <0.001
Macrosomia (≥4 kg) — no. (%)  49 (10)  110 (21)  0.47 (0.34 to 0.64) <0.001
Small for gestational age — no. (%)§  33 (7)  38 (7)  0.88 (0.56 to 1.39) 0.59
5-Min Apgar score <7 — no. (%)  6 (1)  11 (2)  0.57 (0.21 to 1.53) 0.26
Hypoglycemia requiring IV therapy — no. (%)¶  35 (7)  27 (5)  1.42 (0.87 to 2.32) 0.16
Neonatal convulsions — no. (%)  1 (<1)  2 (<1)  0.52 (0.05 to 5.69) 1.00
Respiratory distress syndrome — no. (%)¿  27 (5)  19 (4)  1.52 (0.86 to 2.71) 0.15
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* Plus–minus values are means ±SD. CI denotes confidence interval. Preeclampsia was defined by a blood pressure of at 
least 140/90 mm Hg on two occasions more than four hours apart.
† Values were adjusted for maternal age, race or ethnic group, and parity. The adjusted treatment effect is expressed as the 
mean difference between groups for weight gain from the first visit to the last visit and as the relative risk for all out-
 
comes given as numbers and percentages.
 














No. of antenatal clinic visits after enrollment <0.001
Median 5.0 5.2
Interquartile range 1–7 3–7
No. of physician clinic visits after enrollment <0.001 
Median 3 0
Interquartile range 1–7 0–2
Visit with a dietitian — no. (%)  453 (92) 51 (10) 9.19 (7.08 to 11.94) <0.001
Visit with a diabetes educator — no. (%)  460 (94) 56 (11) 8.56 (6.69 to 10.96) <0.001
Weight gain from first prenatal visit 
to last visit — kg
 8.1±0.3 9.8±0.4  ¡1.4 (¡2.3 to ¡0.4)  0.01
Antenatal admission — no. (%)  141 (29) 139 (27) 1.10 (0.90 to 1.34) 0.34
Antenatal preeclampsia — no. (%)  58 (12) 93 (18)  0.70 (0.51 to 0.95) 0.02
Gestational age at birth — wk  0.01
Median  39.0 39.3
Interquartile range 38.1–40.0 38.3–40.4
Any perineal trauma — no. (%)  255 (52) 254 (50) 1.05 (0.93 to 1.19) 0.42
Postpartum hemorrhage (≥600 ml) — no. (%)  29 (6) 32 (6) 0.96 (0.59 to 1.56) 0.86
Puerperal pyrexia (≥38°C) — no. (%)  17 (3) 29 (6) 0.63 (0.35 to 1.13) 0.12
Length of postnatal stay — days 0.80
Median 4 4
Interquartile range 3–5 3–5
Breast-feeding at hospital discharge — no. (%)  413 (84) 412 (81) 1.04 (0.98 to 1.10) 0.17
 
domized clinical trials on the effects of screening
and treatment of women with gestational diabetes
mellitus. An observational study is currently in
progress to assess associations between maternal





ongoing randomized trial in the United States is
addressing the effect of therapy for mild gestation-




 Our results indicate
that treatment of gestational diabetes in the form
of dietary advice, blood glucose monitoring, and
insulin therapy as required for glycemic control re-
duces the rate of serious perinatal complications,
without increasing the rate of cesarean delivery.
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